|
|
Other links at Articles > Gastroenterology |
| 4. |
Telaprevir Achieves 75% Rate of Sustained HCV Response: Study
|
|
|
Telaprevir, a hepatitis C treatment being developed by Vertex Pharmaceuticals Inc, led to a 75% rate of sustained viral response (SVR) in a pivotal trial of previously untreated patients, the company said on Tuesday. Reuters Health Information
|
| 5. |
Sharp Rise in German E. Coli Cases, Source Unknown
|
|
|
German health officials said on Wednesday there had been a dramatic increase in the number of people infected in an E. coli outbreak which has so far killed 16 and whose source is still unknown. br / iReuters Health Information/i
|
|
|
